These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20610169)

  • 1. Early monitoring of external radiation therapy by [18F]-fluoromethylcholine positron emission tomography and 3-T proton magnetic resonance spectroscopy: an experimental study in a rodent rhabdomyosarcoma model.
    Rommel D; Abarca-Quinones J; Bol A; Peeters F; Lhommel R; Lonneux M; Labar D; Gregoire V; Duprez T
    Nucl Med Biol; 2010 Jul; 37(5):645-53. PubMed ID: 20610169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rodent rhabdomyosarcoma: comparison between total choline concentration at H-MRS and [18F]-fluoromethylcholine uptake at PET using accurate methods for collecting data.
    Rommel D; Bol A; Abarca-Quinones J; Peeters F; Robert A; Labar D; Galant C; Gregoire V; Duprez T
    Mol Imaging Biol; 2010 Aug; 12(4):415-23. PubMed ID: 19937391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced choline metabolism in a rodent rhabdomyosarcoma model: correlation between RT-PCR and translational 3 T H-MRS.
    Rommel D; Abarca-Quinones J; De Saeger C; Peeters F; Leclercq I; Duprez T
    Magn Reson Imaging; 2012 Sep; 30(7):1010-6. PubMed ID: 22513075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography.
    Wehrl HF; Schwab J; Hasenbach K; Reischl G; Tabatabai G; Quintanilla-Martinez L; Jiru F; Chughtai K; Kiss A; Cay F; Bukala D; Heeren RM; Pichler BJ; Sauter AW
    Cancer Res; 2013 Mar; 73(5):1470-80. PubMed ID: 23345160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
    Guo J; Higashi K; Yokota H; Nagao Y; Ueda Y; Kodama Y; Oguchi M; Taki S; Tonami H; Yamamoto I
    J Nucl Med; 2004 Aug; 45(8):1334-9. PubMed ID: 15299058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate moulding: an empirical method for magnetic resonance imaging/positron emission tomography co-registration in a tumor rat model.
    Rommel D; Abarca-Quinones J; Christian N; Peeters F; Lonneux M; Labar D; Bol A; Gregoire V; Duprez T
    Nucl Med Biol; 2008 Jul; 35(5):571-7. PubMed ID: 18589301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography.
    Tozaki M; Sakamoto M; Oyama Y; O'uchi T; Kawano N; Suzuki T; Yamashiro N; Ozaki S; Sakamoto N; Higa K; Abe S; Ogawa T; Fukuma E
    J Magn Reson Imaging; 2008 Aug; 28(2):420-7. PubMed ID: 18666159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
    Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
    AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.
    Kwee SA; Coel MN; Lim J; Ko JP
    J Neuroimaging; 2004 Jul; 14(3):285-9. PubMed ID: 15228773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.
    Tozaki M; Hoshi K
    AJR Am J Roentgenol; 2010 May; 194(5):1384-90. PubMed ID: 20410429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
    Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
    NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total choline at 1H-MRS and [18F]-fluoromethylcholine uptake at PET.
    Kwee S; Ernst T
    Mol Imaging Biol; 2010 Aug; 12(4):424-5; author reply 426. PubMed ID: 20458633
    [No Abstract]   [Full Text] [Related]  

  • 15. Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours.
    Schwarz AJ; Maisey NR; Collins DJ; Cunningham D; Huddart R; Leach MO
    Br J Radiol; 2002 Dec; 75(900):959-66. PubMed ID: 12515704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
    García-Martín ML; Hérigault G; Rémy C; Farion R; Ballesteros P; Coles JA; Cerdán S; Ziegler A
    Cancer Res; 2001 Sep; 61(17):6524-31. PubMed ID: 11522650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
    DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
    Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
    Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
    Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
    van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
    Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.